Edwards Lifesciences CorpEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 85.76 USD | 96,29 USD | 72,3 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 100,962 USD | 10 | 4 | 17 | 0 | 1 |
| #Shares | Short [%] | Short Ratio |
| 575.800.000 | 2,24 | 2,32 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Edwards Lifesciences Corp
Mitarbeiter 16.000
Handelsplatz NYSE
Ticker Symbol EW
IPO Datum 2000-03-27
Adresse One Edwards Way, Irvine, CA, United States, 92614
Webseite https://www.edwards.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Bernard J. Zovighian | CEO & Director |
| 2 | Mr. Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development |
| 3 | Mr. Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies |
| 4 | Ms. Annette Maria Bruls | Corporate Vice President of EMEA, Canada, & Latin America |
| 5 | Ms. Theodora Mistras | Corporate VP & CFO |
| 6 | Mr. Joseph Nuzzolese | Corporate Vice President of Global Operations & Quality |
| 7 | Mr. Andrew M. Dahl | Principal Accounting Officer, Senior VP & Corporate Controller |
| 8 | Dr. Todd Brinton FACC, M.D. | Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer |
| 9 | Mr. Snehashish Sarkar | Senior VP and Chief Information & Digital Officer |
| 10 | Mr. Mark D. Peterson | Corporate VP & General Counsel |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 7 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 8 | Bank of New York Mellon Corp | 0,00% | 0,00 Mio. USD |
| 9 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 10 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Jennison Associates LLC | 0,00% | 0,00 Mio. USD |
| 12 | DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main | 0,00% | 0,00 Mio. USD |
| 13 | Ninety One UK Limited | 0,00% | 0,00 Mio. USD |
| 14 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 15 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 16 | Brown Advisory Holdings Inc | 0,00% | 0,00 Mio. USD |
| 17 | Deutsche Bank AG | 0,00% | 0,00 Mio. USD |
| 18 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 19 | UBS Asset Mgmt Americas Inc | 0,00% | 0,00 Mio. USD |
| 20 | Artisan Partners Limited Partnership | 0,00% | 0,00 Mio. USD |